hVIVO Services Limited
Innovation Centre
42 New Road
London
E1 2AX
United Kingdom
Tel: 44-0-20-7756-1300
Website: http://hvivo.com/
About hVIVO Services Limited
hVIVO plc ("hVIVO"), a specialty biopharma company with discovery and clinical testing capabilities, is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. Leveraging human disease models in flu, RSV and asthma exacerbation, the hVIVO platform captures disease in motion, illuminating the entire disease life cycle from healthy to sick and back to health. Based in the UK, market leader hVIVO has conducted more than 45 clinical studies, inoculated over 2000 volunteers and has three first-in-class therapies currently in development with a growing pre-clinical pipeline.YEAR FOUNDED:
1988
LEADERSHIP:
CEO: Kym Denny
CFO and CBO: Graham Yeatman
JOBS:
Please click here for hVIVO job opportunities.
2 articles about hVIVO Services Limited
-
Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK
5/11/2020
Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, and hVIVO, part of Open Orphan plc, announced that the MosaiQâ„¢ by Quotient system and MosaiQ COVID-19 Antibody Microarray will be used by hVIVO to screen for SARS-CoV-2 antibodies.
-
hVIVO Services Limited Notes The Initiation Of A Phase I Clinical Trial With AGS-V, A Mosquito-Borne Disease Vaccine Candidate
2/21/2017